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Background: Antibiotic resistance is a global threat to patient safety and care. In response, hospitals start antibiotic
stewardship programs to optimise antibiotic use. Expert-based guidelines recommend strategies to implement such
programs, but local implementations may differ per hospital. Earlier published assessments determine maturity of
antibiotic stewardship programs based on expert-based structure indicators, but they disregard that there may be
valid deviations from these expert-based programs.
Aim: To analyse the progress and barriers of local implementations of antibiotic stewardship programs with stakeholders
in nine Dutch hospitals and to develop a toolkit that guides implementing local antibiotic stewardship programs.
Methods: An online questionnaire based on published guidelines and recommendations, conducted with seven clinical
microbiologists, seven infectious disease physicians and five clinical pharmacists at nine Dutch hospitals.
Results: Results show local differences in antibiotic stewardship programs and the uptake of interventions in hospitals.
Antibiotic guidelines and antibiotic teams are the most extensively implemented interventions. Education, decision
support and audit-feedback are deemed important interventions and they are either piloted in implementations
at academic hospitals or in preparation for application in non-academic hospitals. Other interventions that are
recommended in guidelines - benchmarking, restriction and antibiotic formulary - appear to have a lower priority.
Automatic stop-order, pre-authorization, automatic substitution, antibiotic cycling are not deemed to be worthwhile
according to respondents.
Conclusion: There are extensive local differences in the implementation of antibiotic stewardship interventions.
These differences suggest a need to further explore the rationale behind the choice of interventions in antibiotic
stewardship programs. Rather than reporting this rationale, this study reports where rationale can play a key role
in the implementation of antibiotic stewardship programs. A one-size-fits-all solution is unfeasible as there may
be barriers or valid reasons for local experts to deviate from expert-based guidelines. Local experts can be
supported with a toolkit containing advice based on possible barriers and considerations. These parameters can
be used to customise an implementation of antibiotic stewardship programs to local needs (while retaining its
expert-based foundation).
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Antibiotic resistance is an increasing worldwide threat
to patient safety and quality of care [1,2]. A correlation
between antibiotic (over) use and increasing antibiotic
resistance is widely acknowledged [3]. Hospitals can in-
fluence antibiotic use with improved, prudent antibiotic
prescription, as up to 50% of prescribed antibiotics may
be inappropriate or even unnecessary [4]. To curb the
increasing resistance, hospitals started antibiotic stew-
ardship programs (ASPs) as quality initiatives for infec-
tion prevention and control. An ASP ensures proper use
of antibiotics with the best patient outcomes, less risk of
adverse effects, optimal cost-effectiveness and to reduce
or stabilise levels of resistance [5]. Guidelines from
professional societies, such as the Infectious Diseases
Society of America/Society for Healthcare Epidemiology
of America (IDSA/SHEA) recommend expert-based strat-
egies and interventions to implement ASPs in hospitals
[6-8]. In the Netherlands, the Dutch Working Party on
Antibiotic Policy (SWAB) is responsible for guideline
development, education and surveillance for optimal anti-
biotic use. This organisation recently published a vision
document, stressing the need for Dutch hospitals to form
an ASP team and start planning future ASP initiatives as
per January 2014 [9].
There is no consistent approach in local implementa-
tions of ASP in hospitals [10]. Hospitals combine expert-
based strategies and subsequent ASP interventions in
many different variations [4]. In a prior systematic re-
view, neither a consistent implementation strategy nor a
sufficiently described implementation rationale could be
identified in international ASP studies (van Limburg M,
Köck R, Karreman J, Sinha B, de Jong N, Wentzel J,
Friedrich A, Hendrix R, van Gemert-Pijnen J, “Towards
an Implementation Strategy for Antibiotic/Antimicrobial
Stewardship: A Systematic Review”, Under review). To
understand how these local implementations of ASP take
form it is important to use a bottom-up analysis from
within hospitals. In this approach, we involve the relevant
local stakeholders in the hospitals we aim to assist with
implementing ASP, as opposed to an expert-driven or
authoritative top-down approach.
Progression in implementation can be assessed with
the concept of ‘maturity’. Maturity models were first
coined by Paulk et al [11] and are used in many disci-
plines to model or evaluate improvement of organisa-
tions and processes [12]. Maturity models describe a
levelled progress of how, in this case, an ASP implemen-
tation gradually improves from an ad-hoc state to a
structured and managed state and eventually to a meas-
urable and self-optimizing state [11].
Maturity assessments are already used in the context
of ASP. Earlier maturity assessments of ASPs were done by
the Antibiotic Strategy International group who introduceda comprehensive list of potential structure indicators to as-
sess maturity of ASP in hospitals in several European
countries [13]. In short, this means that maturity of ASP
depends on the number of expert-based structure indica-
tors that are implemented as part of ASP in a hospital.
This study does not attempt to assess maturity by
scoring a completeness of an ideal program, but ana-
lyses differences in local implementations of ASP in-
terventions that are recommended in guidelines. Our
aim is not primarily to identify which interventions
are or should be implemented, but more importantly,
to identify where rationale plays a role in implement-
ing ASP interventions and what the consequences are
for expert-based ASP strategies. The present study is
the first step in our bottom-up assessment with local
ASP experts to give an overview of which recommended
interventions are implemented, or are being developed,
combined with an importance analysis of these inter-
ventions. Incongruent responses from stakeholders show
where possible difficulties or barriers surface when imple-
menting ASP conform currently available expert guide-
lines and indicate possibilities for decision support. A
follow-up study is required to understand the deeper
rationale behind these differences and barriers and how
local experts can be assisted with relevant implementation
advice.
Methods
An online questionnaire using LimeSurvey was made
available from August to November 2013. Clinical mi-
crobiologists, clinical pharmacists and infectious disease
physicians were approached as these expert types are iden-
tified as being key-stakeholders in ASP (van Limburg M,
Köck R, Karreman J, Sinha B, de Jong N, Wentzel J,
Friedrich A, Hendrix R, van Gemert-Pijnen J, “Towards
an Implementation Strategy for Antibiotic/Antimicrobial
Stewardship: A Systematic Review”, Under review). Eth-
ical approval was given after revision by an internal rep-
resentative of the ethical board (reference: BCE14039)
and no further ethical review procedures were deemed
necessary. We sent a questionnaire invitation to known
infection control experts recruited in earlier research
projects. These experts represented academic and non-
academic hospitals in the Dutch eastern border region
and they were asked to distribute the questionnaire
among clinical microbiologists, clinical pharmacists and
infectious disease physicians tasked with ASP in their
hospitals. As at the time of the questionnaire ASP teams
were not necessarily formed at the hospitals yet, we chose
to approach key stakeholders rather than teams directly.
We also analysed the response of key stakeholders indi-
vidually (not clustered per hospital) as stakeholders may
have possible differences in views on ASP interventions
(even within hospitals).
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mentation topics based on a literature review (see Table 1).
The topics that were addressed involved ASP program ini-
tiatives, presence and importance of commonly used inter-
ventions and their possible characteristics, and possible
outcomes and effects relevant for assessing evidence for
the effectiveness of ASP. The extraction of implementa-
tion topics concerning ASP maturity or implementation
assessments, attitude or opinion surveys towards ASP or
practical implementation toolkits for ASP are presented in
detail in Table 1.
The final questionnaire was adapted for the Dutch
healthcare context, reduced and validated by microbiolo-
gists to have a final scope of 47 questions for an accept-
able answering duration of 15–20 minutes. A literal
English translation of the Dutch questionnaire can be
found in Additional file 1 for reference.
Responses were imported into SPSS21 for statistical
analysis. Incomplete responses were excluded. Frequency
cross-tables of responses stratified by hospital type
(academic/non-academic) were used for reporting all




A total of 27 responses were collected. Eight respon-
dents started answering the first few questions but did
not complete the questionnaire and had to be excluded
from the results. Based on the first questions we could
identify that these were three clinical microbiologists,
one infectious disease physician and four clinical phar-
macists. Nineteen respondents completed the question-
naire, and the final sample consists of seven clinical
microbiologists, seven infectious disease physicians and
five clinical pharmacists from three academic hospitals
and six non-academic (general tertiary care) hospitals.
Antibiotic stewardship program initiatives
The three included academic hospitals have implemented
an ASP. At the non-academic hospitals, ASP initiatives
are in development at five hospitals while one hospital
has implemented an ASP. Almost all ASP initiatives were
started from 2012 onwards.
Respondents from academic hospitals seemed more
satisfied with current mandate from hospital management,
available budgets and assigned full-time equivalents (FTEs)
than their non-academic peers. No consensus was found in
their opinions regarding satisfaction with the level of for-
malisation of ASP with, for example, documentation or
task descriptions.
Academic hospitals targeted multiple wards in their ASP
implementations, but the type of wards varied. Generally
these were all wards with high risk of infections and withrelatively high antibiotic use. Most non-academic hospitals
did not yet implement ASP. There, however, is a strong
consensus that eventually ASPs should be implemented
throughout the entire hospital.
Implementation of ASP interventions
Table 2 provides an overview of the maturity assessment
as to whether common ASP interventions were already
implemented, in development, considered necessary or
considered unnecessary. The following paragraphs dis-
cuss the interventions in more detail.
Antibiotic team
In the early stages of ASP implementation, an antibiotic
team (usually called A-team for obvious reasons) is
mostly responsible for preparing an ASP. Subsequently,
their tasks change to monitoring ASP effectiveness and
performing important tasks that are part of the program.
Based on the response, we can assume antibiotic teams
were either already formed or in preparation.
Table 3 shows the composition of these teams. In both
types of hospitals the antibiotic teams consist of at least
infectious disease physicians, clinical microbiologists and
clinical pharmacists. These are also the stakeholders rec-
ommended to be at least present according to the national
guidelines endorsed by SWAB [9]. Other stakeholders are
involved in different team configurations but there is no
consensus on which of these other stakeholders should be
definite members of the antibiotic team. In both types of
hospitals it is clear that management and attending physi-
cians have no active role in the team.
In non-academic hospitals, the frequency of infectious
disease physicians in the teams is lower compared to
academic hospitals. This can be explained by the prob-
ability that non-academic hospitals have no or too few
(e.g. shared with other local hospitals) infectious disease
physicians available, hence they cannot take part in their
antibiotic team.
(Local) Antibiotic guidelines
There are national antibiotic guidelines to which Dutch
hospitals have to comply, based on evidence or expert-
based guidelines and policies established in academic
hospitals (e.g. available at www.swabid.nl). Hospitals are
at liberty to use these national guidelines in full or adapt
them slightly into local antibiotic guidelines.
Table 4 shows that academic hospitals have most com-
mon types of antibiotic guidelines locally implemented and
overall, respondents were satisfied with currently available
antibiotic guidelines in their hospitals. They responded that
guidelines for intravenous-per os switches and for de-
escalation are not yet available, but needed.
The situation in non-academic hospitals is different.
Guidelines for treatment of infections, antibiotic therapy
Table 1 Overview of literature scan and extracted implementation topics
# Author (s) Year Title Study description Extracted implementation topics
1 Bannan, Buono, McLaws,
Gottlieb
2009 Survey of medical staff attitudes
to an antibiotic approval and
stewardship program
Design: − restriction as intervention
Questionnaire with 40 questions
focused on restriction and
approval
− authorization as intervention
Interest: − advice as communication
− education as intervention
Attitude − stop-order (withholding pharmacy)
as intervention
− costs, appropriate use, resistance,
time as outcomes
− pager as communication
− possible stakeholders in team
2 Barlam, DiVall 2006 Antibiotic-stewardship practices
at top academic centers
throughout the united states
and at hospitals throughout
Massachusetts
Design: − multifaceted programs
Two surveys − time of start with ASP
Interest: − funding/financial support
ASP components − (formulary) restriction as
intervention
− solicited input from ID as
communication
− costs, improved use, adverse
effects, resistance, compliance,
DDDs, clinical outcomes as
outcomes
− aiming prophylaxis
− aiming only targeted antibiotics
− aiming antibiotic therapy at order
− aiming initial therapy
− recommendations as intervention
(day 3 bundle)
− culture data as communication
− possible stakeholders in team
− approval as intervention
− review as communication
− consult as communication
− computerized order entry as
communication
− stop-order as intervention
− IV-PO switch as intervention
− clinical practical guidelines as
intervention
− evaluation as intervention
(benchmarking)
− support and time needed from
physicians




2008 Hospital antibiotic management
in Austria – results of the ABS
maturity survey of the ABS
International group
Design: − data evaluation as intervention
(benchmarking)
Survey − AB consumption data as outcomes
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Table 1 Overview of literature scan and extracted implementation topics (Continued)
Interest: − hospital/department/ward levels
of benchmarking
5 categories of maturity − feedback of benchmarking as
communication
− possible stakeholders in team
− guidelines for dosage, drug costs,
IV-PO switch
− guidelines for antibiotic treatment
− guidelines for prophylaxis
− education as intervention
(seminars, literature)
− financial resources
− cooperation with other hospitals
4 Buyle, Metz-Gercek, Mechtler,
Kern, Robays, Vogelaers,
Struelens





Design: − bedside advice as communication
Expert panel + validation survey − rounds as intervention
− frequency of team meetings
Interest: − audit as intervention
Potential structure indicators
for ASP
− possible stakeholders in team
− formulary as intervention
− updating formulary
− stop order as intervention





− clinical decision aid as IT
− mandate from management
− FTEs
− Education as interventions
− passive methods, interactive
methods as education
− evaluation as intervention
− resistance data, consumption data,
− hospital/department/ward levels
of benchmarking
− total DDDs, # of infections as
outcomes
5 Cooke, Alexander, Charani,
Hand, Hills, Howard, Jamieson,
Lawson, Richardson, Wade




Design: − guidelines as intervention
ASAT toolkit (checklist) − formulary as intervention
Interest: − restriction as intervention
Levels of antimicrobial
stewardship
− IV-PO switches as intervention
− guidelines for prophylaxis as
intervention
− adherence as outcome
− education as intervention
− training as education
− information systems as IT
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Table 1 Overview of literature scan and extracted implementation topics (Continued)
− digital prescribing as IT
− possible stakeholders in team
6 Dumartin, Rogues, Amadeo,
Pefau, Venier, Parneix, Maurain
2011 Antibiotic stewardship programmes:
legal framework and structure and
process indicator in Southwestern
French hospitals, 2005–2008
Design: − frequency in meetings
Survey − available human resources
Interest: − digital prescription, pharmaceutical
analysis, dispensation, digital link
between lab, pharm, wards as IT
Checking whether legal
framework is present
− restriction as intervention
− stop order as intervention
− first-line, prophylaxis as guidelines
− audits as intervention/
communication
− evaluation feedback as
communication
− education as intervention
− Formulary as intervention
− ab consumption as benchmarking
− DDDs, resistance as outcomes
(and communication)
− possible stakeholders in team
7 van Gastel, Costers, Peetermans,
Struelens
2010 Nationwide implementation of
antibiotic management teams in
Belgian hospitals: a self-reporting
survey
Design: − Possible stakeholders in team
Questionnaire − consultation per phone, email,
intranet, face-to-face, staff
meetings as communication
Interest: − formulary as intervention
Level of AMT activities − guidelines for empirical and
prophylaxis
− updates of formulary and
guidelines
− restriction as intervention
− approval/review as intervention
− concurrent review/audit as
intervention
− de-escalation as intervention
− stop order as intervention
− order forms as intervention
− IV-PO switch as intervention
− consumption and resistance as
outcomes
− by hospital/unit or by antibiotic
type
− feedback of outcomes
8 Greater New York Hospital
Association
2011 Antimicrobial stewardship toolkit Design: − benchmark and review antibiotic
use (patterns)
Best practice − review resistance
Interest: − IT infrastructure
Implementation toolkit − possible stakeholders in team
− aim for common infections,
pathogens, agents
− rollout: hospital vs. ward
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Table 1 Overview of literature scan and extracted implementation topics (Continued)
− available resources
− strategy:
− guidelines for diagnosis, treatment,
duration, dose optimization, IV-PO,
streamlining/de-escalation
− formulary as intervention
− restriction as intervention
− education as intervention
− prospective review as intervention
− stickers, notes, face-to-face as
communication
− data collection (benchmarking)
− usage, clinical, microbiologic,
costs as data
9 Hulscher, Grol, van der Meer 2010 Antibiotic prescribing in hospitals:
a social and behavioral scientific
approach
Design: − formulary as intervention
Review − order form as intervention
Interest: − restriction as intervention
socio-cultural factors of ASP − stop orders as intervention
− infection control committee
− guidelines as intervention
− review as intervention
− rounds as intervention
− telephone advice as intervention
− improve infrastructure
− education as intervention
− conferences, seminars, skill
training programs as education
− individual instructions (outreach,
academic detailing)
− feedback of outcomes
− decision support via IT
10 Nault, Beaudoin, Thirion,
Gosselin, Cossette, Valiquette
2008 Antimicrobial stewardship in
acute care centres: survey of
68 hospitals in Quebec
Design: − Duration of ASP or busy setting up
Questionnaire − distributed units, DDDs, acquisition
costs as benchmarking data




− education as intervention
− stop orders as intervention
− auto substitution
− formulary restriction as
interventions
− local guidelines as intervention
− preauthorization as intervention
− antibiotic cycling as intervention
− decision support systems as
intervention
− possible stakeholders in team
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Table 1 Overview of literature scan and extracted implementation topics (Continued)
11 Pulcini, Williams, Molinari,
Davey, Nathwani
2011 Junior doctors’ knowledge and
perceptions of antibiotic resistance
and prescribing: a survey in France
and Scotland
Design: − local guidelines as intervention
Survey − presence of team-
Interest: − approval as intervention
Perception and prescribing
practice
− IV-PO switch protocol
− advice from ID physician, senior,
microbiologist, pharmacist or
team as intervention
− face-to-face, phone, consult upon
request as communication
− lectures, workshops, informal
education, web-based learning,
self-directed learning as education
− possible stakeholders in team
− computer aided prescribing as IT
− resistance data availability
12 Thern 2013 Selection of hospital antimicrobial
prescribing quality indicators:
Design: − possible stakeholders in team
a consensus among German
antibiotic stewardship (ABS)
networkers
Review+ − frequency of meetings
questionnaire − mandate
Interest: − drug use, resistance rates as data
Indicators for quality of AB
prescribing
− formulary as intervention
− updating formulary
− restriction/approval as intervention
− guidelines for empiric therapy,
IV-PO, dosing, prophylaxis,
− rounds as intervention
− education as intervention
− guidance or assisted decision
analysis via IT
13 Trivedi, Rosenberg 2013 The state of antimicrobial
stewardship programs in
California
Design: − implemented or planned ASP
Survey − time of start with ASP
Interest: − possible stakeholders in team
State of ASP − FTE availability
− - funding
− benchmarking as intervention
− DDDs, DOTs, costs, acceptance
of recommendations, improved
susceptibility patterns as data
− use of IT in ASP
− electronic health record, digital
prescription, electronic medication
administration records as IT
− formulary restriction as intervention
− ID physician consult as intervention
− audit as intervention
− prior approval as intervention
− auto stop orders as intervention
− verbal approval as intervention
− pre-authorization as intervention
van Limburg et al. Antimicrobial Resistance and Infection Control 2014, 3:33 Page 8 of 15
http://www.aricjournal.com/content/3/1/33
Table 1 Overview of literature scan and extracted implementation topics (Continued)
− education as intervention
− guidelines as intervention
− IV-PO switch as intervention
− streamlining/de-escalation as
intervention
− order forms as intervention
*) DDDs: daily defined doses; DOT: days of therapy; FTE: full-time equivalent; ID: infectious diseases; IV-PO: intravenous-per os; IT: information technology.
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as national antibiotic guidelines). However, other anti-
biotic guidelines are incomplete and not as available
when compared to academic hospitals. Respondents from
non-academic hospitals agree that additional antibiotic
guidelines are needed. It is interesting to see that exactly
those guidelines that academic hospitals expressed as being
needed (intravenous-per os switches and de-escalation) are
in development at non-academic hospitals.
Antibiotic formulary
An antibiotic formulary contains an overview of indica-
tions and favourable antibiotic treatment (s). In the
Netherlands, these formularies are usually introduced and
maintained by the clinical microbiologists. Overall, an anti-
biotic formulary is present in both types of hospitals.
Audit-and-feedback
Audits are interactions with prescribers to influence the
way they prescribe for antibiotic therapy. These audits
can be prospective, thus directly influence therapy
with feedback at patient level, or retrospective where theTable 2 Maturity of ASP interventions in academic and non-a
Academic hospitals
Impl In dev Need Unneed
Antibiotic team 6 (75%) 2 (25%) -
(Local) antibiotic guidelines 7 (88%) 1 (12%) - -
Antibiotic formulary 7 (88%) 1 (13%) - -
Audit-and-feedback 3 (38%) 2 (25%) 2 (25%) -
Education 4 (50%) 4 (50%) - -
Information systems for ASP 2 (25%) 1 (13%) 5 (63%) -
Benchmarking 4 (50%) 3 (38%) - 1 (13%)
Restriction 2 (25%) 4 (50%) 1 (13%) 1 (13%)
Academic detailing 1 (13%) 3 (38%) 3 (38%) -
Automatic stop-order - 1 (13%) 4 (50%) 2 (25%)
Pre-authorization 1 (13%) 1 (13%) 3 (38%) 1 (13%)
Automatic substitution - 1 (13%) 2 (25%) 5 (63%)
Antibiotic cycling - 1 (13%) 1 (13%) 4 (50%)
*) Impl: implemented; in dev: in development; need: are needed; unneed: are unneprescribed antibiotics are assessed and reported back to
prescribers.
The response (see Table 2) from respondents at academic
hospitals is diverse and suggests audits are performed but
still as a pilot in only a few wards. As Figure 1 depicts,
there is no clear preference for bedside or remote consults
as form of audit, but retrospective feedback seems less
preferred.
At non-academic hospitals audits do not yet take place
but are in either in development or considered neces-
sary. Compared to academic hospitals the respondents
of non-academic hospitals have a slightly stronger prefer-
ence for bedside audits over remote audits via phone or
email as can be seen in Figure 1. All respondents stated
audit-and-feedback was the preferred strategy for ASP.
Education
Educational activities are needed to disseminate the goals
and interventions of ASP among prescribers and other
possible stakeholders for ASP. At academic hospitals,
educational activities implemented or in development
relatively equally, suggesting it this is something that iscademic hospitals
Non-academic hospitals
N/A* Impl In dev Need Unneed N/A*
- 6 (55%) 5 (45%) - - -
- 9 (82%) 2 (18%) - - -
- 8 (73%) 2 (18%) 1 (9%) - -
1 (13%) - 4 (36%) 6 (55%) 1 (9%) -
- 2 (18%) 8 (73%) 1 (9%) - -
- 2 (18%) 4 (36%) 3 (27%) - 2 (18%)
- 1 (9%) 7 (64%) 2 (18%) - 1 (9%)
5 (45%) 3 (27%) 1 (9%) 2 (18%)
1 (13%) 2 (18%) 2 (18%) 4 (36%) - 3 (27%)
1 (13%) - 4 (36%) 3 (27%) 2 (18%) 2 (18%)
2 (25%) - 2 (18%) 3 (27%) 1 (9%) 5 (45%)
- 1 (9%) 3 (27%) 2 (18%) 5 (45%)
2 (25%) - - 5 (45%) 2 (18%) 4 (36%)
eded; N/A: no answer or not applicable.
Table 3 Composition of antibiotic team in academic and non-academic hospitals
Academic hospitals Non-academic hospitals
Impl In dev Need Unneed N/A* Impl In dev Need Unneed N/A*
Clinical microbiologist 8 (100%) X - - 9 (82%) X 1 (9%) - 1 (9%)
Infectious disease physician 8 (100%) X - - 5 (45%) X - 1 (9%) 5 (45%)
Clinical pharmacist 7 (88%) X 1 (13%) - 9 (82%) X 1 (9%) - 1 (9%)
Member of antibiotic committee 5 (63%) X 1 (13%) - 2 (25%) 4 (36%) X 3 (27%) 1 (9%) 3 (27%)
Prescribing physician 4 (50%) X - 3 (38%) 1 (13%) - X 4 (36%) 3 (27%) 4 (36%)
Hygienist 1 (13%) X 3 (38%) 3 (38%) 1 (13%) 1 (9%) X 3 (27%) 4 (36%) 3 (27%)
IT specialist - X 3 (38%) 4 (50%) 1 (13%) - X 4 (36%) 5 (45%) 2 (18%)
Nurse - X 3 (38%) 3 (38%) 2 (25%) - X 2 (18%) 5 (45%) 4 (36%)
Epidemiologist 1 (13%) X 4 (50%) 1 (13%) 2 (25%) - X 1 (9%) 4 (36%) 6 (55%)
Management - X - 6 (75%) 1 (13%) - X 2 (18%) 6 (55%) 2 (18%)
Supervising physician 1 (13%) X 1 (13%) 5 (63%) 1 (13%) - X 1 (9%) 6 (55%) 4 (36%)
*) Impl: implemented; in dev: in development; need: are needed; unneed: are unneeded; N/A: no answer or not applicable.
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tals have progressed less with implementing education
and hence educational activities are still contemplated or
in development. Respondents of both types of hospitals
have a strong preference for workshops as means of
education (Figure 2).
Information systems for ASP
Specific information systems (information technology or
software) that can be used in ASP were present at aca-
demic hospitals, except for information systems to evaluate
prescriptions and decision support tools, e.g. for informa-
tion while performing audits.
At non-academic hospitals, the presence of informa-
tion systems was more divided than at their academic
peers and not generalizable, but information systems for
ASP are mostly in development Table 5.
Benchmarking
Benchmarking or monitoring antibiotic use related out-
comes is necessary to assess changes caused by ASP.Table 4 Status of antibiotic guidelines in academic and non-a
Academic hospitals
Impl In dev Need Unneed
Diagnosis of infections 8 (100%) - - -
Treatment of infections 8 (100%) - - -
Antibiotic therapy 8 (100%) - - -
Duration of therapy 7 (88%) - 1 (13%) -
Prophylaxis 8 (100%) - - -
IV-PO switches 5 (63%) - 3 (38%) -
De-escalation/streamlining 3 (38%) 1 (13%) 4 (50%) -
*) Impl: implemented; in dev: in development; need: are needed; unneed: are unneSuch data can be compared internally (e.g. over time,
between wards, between prescribers, etc.) and externally
(e.g. between hospitals, nationally, internationally, etc.).
Antibiotic teams at academic hospitals that benchmark
or have it in development have access to common data
sources for benchmarking. In non-academic hospitals
benchmarking is less present and still in development,
hence most data sources are not (yet) available either
to the antibiotic team. Figure 3 gives an overview of
the available (or in case of non-academic hospitals, in
development) data sources. The figure suggests that daily
defined doses and antibiotic costs are relatively the most
used data types for benchmarking and monitoring anti-
biotic use.
Restriction
Restriction of antibiotics means prescription of some
or all antibiotics requires validation by a member of
the antibiotic team. This intervention is not com-
monly present in academic hospitals, but stated as be-
ing in development. Current and future application ofcademic hospitals
Non-academic hospitals
N/A* Impl In dev Need Unneed N/A*
- 4 (36%) - 3 (27%) - 4 (36%)
- 7 (64%) 2 (18%) - - 2 (18%)
- 10 (91%) 1 (9%) - - -
- 5 (45%) 2 (18%) 3 (27%) - -
- 10 (91%) 1 (9%) - - -
- 3 (27%) 4 (36%) 4 (36%) - -
- 1 (9%) 4 (36%) 5 (45%) - -
eded; N/A: no answer or not applicable.
Figure 1 Preferences for audit.
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hospitals. None of the respondents indicated that restric-
tion and (pre)-approval were identified as key strategies
for ASP.
Academic detailing
Academic detailing means that prescribers are influenced
with structural evidence-based feedback, where the aca-
demic evidence plays an important role in the feedback
as a form of education. This is hardly used in both types
of hospitals but respondents stated this intervention is in
either development or needed in the longer term. Cur-
rently there can be some ad-hoc academic explanation
in feedback, but ‘academic detailing’ as a structural
intervention that structurally provides prescribers with
evidence-based feedback, is not seen as an important,
urgent intervention according to our respondents.
Automatic stop-order, pre-authorisation, automatic
substitution and antibiotic cycling
Respondents of non-academic hospitals stated that these
four interventions are all in development or needed.
Academic hospitals appear to be only interested in de-
veloping automatic stop-orders or pre-authorisation as
automatic substitution and antibiotic cycling were often
stated as being unnecessary.Figure 2 Preferences for education.Importance of ASP interventions
Respondents were asked in the questionnaire to rank
ASP interventions. The list contained thirteen ASP in-
terventions respondents could rank in order of import-
ance to their ASP with a 1 to 13 score. Final scores in
Figure 4 were averaged per type of hospital and overall
average. The median of 7 was plotted to emphasize the
perceived relative importance of interventions.
Local antibiotic guidelines and an antibiotic team are
scored as the two currently most important interven-
tions for implementing ASP in both types of hospitals.
Education and audit-and-feedback scored relatively high
as well, and in combination with earlier data in Table 2,
they can be seen as part of a primary ASP bundle. Deci-
sion support systems receive more attention in non-
academic hospitals than in academic hospitals. A possible
explanation for this is the higher preference for bedside
audits in non-academic hospitals (see Table 2) since for
audits such decision support systems are particularly help-
ful. Less direct attention is needed for restrictive measures,
an antibiotic formulary, academic detailing and bench-
marking. We think an explanation for the low score for
antibiotic formularies is that most Dutch hospitals already
have such formularies in place and as such they are
not directly seen as a specific, important intervention of
ASP. The remaining interventions, automatic stop-order,
Table 5 Status of information systems for ASP in academic and non-academic hospitals
Academic hospitals Non-academic hospitals
Impl In dev Need Unneed N/A* Impl In dev Need Unneed N/A*
Electronic health records 5 (63%) 2 (25%) 1 (13%) - - 9 (82%) 2 (18%) - - -
Digital laboratory data 6 (75%) 1 (13%) 1 (13%) - - 6 (55%) 1 (9%) 3 (27%) - 1 (9%)
Digital antibiotic use data 7 (88%) - - - 1 (13%) 4 (36%) 3 (27%) 2 (18%) - 2 (18%)
Digital precribing 8 (100%) - - - - 7 (64%) 3 (27%) 1 (9%) - -
Evaluation of prescription 2 (25%) 4 (50%) 2 (25%) - - 1 (9%) 2 (18%) 5 (45%) - 3 (27%)
Decision support systems 1 (13%) 2 (25%) 3 (38%) - 2 (25%) 1 (9%) 4 (36%) 4 (36%) 1 (9%) 1 (9%)
Surveillance 6 (75%) 1 (13%) - 1 (13%) 3 (27%) 4 (36%) 4 (36%) - -
*) Impl: implemented; in dev: in development; need: are needed; unneed: are unneeded; N/A: no answer or not applicable.
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cycling score relative low on importance and it is ques-
tionable whether these are interesting interventions for
ASP.
Discussion
Both academic hospitals and non-academic hospitals in
the Dutch border region are busy with antibiotic stew-
ardship initiatives. When assessing local implementa-
tions of ASPs, a clear difference in academic and
non-academic hospitals can be seen. Generally, academic
hospitals are experimenting with comprehensive pro-
grams of recommended interventions in pilot ASPs.
Non-academic hospitals have implemented interventions
that are required by national guidelines and are expand-
ing the program with other important interventions for a
comprehensive ASP. Obviously the academic nature and
larger size of academic hospitals support a more experi-
mental, comprehensive approach, whereas non-academic
hospitals seem to take a more practical approach by
focusing on easily obtained gains first. Some existing pro-
cesses can be reused as many activities that are now
under the ASP umbrella are not necessarily new. For
example, many hospitals have had remote consults
with microbiologists in place for years. Also, this dif-
ference between academic and non-academic hospitals is
strengthened by the fact that non-academic hospitalsFigure 3 Preferences for data sources for benchmarking. *) DDDs: dailseem to have more difficulties in securing adequate re-
sources for ASP.
When we combine maturity modelling with the find-
ings of the current progress in ASP in hospitals included
in our questionnaire, a number of conclusions can be
drawn:
– In the state before ASP really starts, the null or m0
state of a maturity model, most Dutch hospitals
already have a comprehensive antibiotic formulary
and at least guidelines for treatment of infections,
antibiotic therapy and prophylaxis. This is helpful as
it can be a head start for implementing ASPs. In
many other countries such an antibiotic formulary
did not yet exist and is usually an important first
ASP activity of the antibiotic team (van Limburg M,
Köck R, Karreman J, Sinha B, de Jong N, Wentzel J,
Friedrich A, Hendrix R, van Gemert-Pijnen J,
“Towards an Implementation Strategy for Antibiotic/
Antimicrobial Stewardship: A Systematic Review”,
Under review).
– In the first stage of maturity, the initial phase,
processes are ad-hoc and unorganised [11]. We found
that hospitals are triggered by the SWAB vision
document [9] and data from the questionnaire
suggests that stakeholders are busy with a primary
bundle of interventions that constitute an ASP. Any defined doses; DOT: days of therapy.
Figure 4 Ranking of relative importance of ASP interventions.
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ASP, educational activities and an audit-and-feedback
intervention receive early attention and seem to be the
first interventions to be implemented when hospitals
start with ASP. However, it seems each intervention is
implemented quite differently, according to local
contexts and readily available means. In other
words, interventions are implemented with a slight
variation between them. For example, an intervention
that seems rather straight-forward is an antibiotic
team, however, the composition of an antibiotic team
is already quite different in each hospital, depending
on the available staff, and care focuses (children,
trauma, etc.) in that hospital.
– The second stage of maturity, a managed state, is
what regulatory documents aim for. There is a risk
that the current proliferation of local ASPs and local
variations between interventions in hospitals are
unstandardized and will therefore be difficult to
regulate, compare and manage. For example, how
does a team with an ID physician relate to a team
without? Timely guidelines that help standardisation
are necessary. From a regulatory perspective, two
scenarios are possible: a) allow proliferation and wait
until a dominant design emerges – assuming that
over time current ASPs will evolve into comparable
programs or b) interact with hospitals and
understand the local differences and anticipate
with the regulations.
– Further stages of maturity, which is a measured and
self-optimising state, is difficult to achieve for ASPs
in their current state. Standardisation in processesand measurements are necessary to evaluate ASPs
both internally and externally. We found that data
collection for benchmarking can be done; however,
as ASPs are currently novel and diverse between
hospitals, this would be like comparing apples and
oranges. Also, although there is evidence that ASPs
show positive effects on antibiotic use and antibiotic
resistance [14,15], there is little or no standardisation
in how effectiveness of ASPs is measured in terms of
standardised outcomes or even methodologies [16,17].
That is also causing difficulties to compare (different)
programs.
The assessment of the implementation of ASP can be
expanded further by understanding the rationale and
considerations local experts have based on expert-based
recommendations in available regulatory documents.
Patel et al. concluded that little guidance is offered on
the practical aspects of implementing ASPs and that
non-academic hospitals in the US need to overcome
implementation issues by accounting for unique charac-
teristics of their institutions [18]. Understanding these
issues combined with these unique characteristics can
eventually be used for parameters to customise local
implementations of expert-based recommendations.
Earlier maturity assessments identified a set of struc-
ture indicators or characteristics that need to be present
[13,19]. Prudence should be shown to assess the matur-
ity of ASP implementation when using these structure
indicators, as local experts may have valid reasons to de-
viate from expert recommendations. For example, a
non-academic hospital may not have infectious disease
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lar tasks. If available maturity assessments are strictly
observed, this example hospital is missing an important
structure indicator, while in practice the ASP was imple-
mented differently from the ideal program as proposed
and assessed by experts. Therefore, tallying whether
expert-recommended interventions are present is not
enough to capture the progress and maturity of ASP
implementations.
By applying convenience sampling, we contacted re-
spondents indirectly via infection control experts in the
Dutch eastern border region and we depended on their
willingness and involvement with ASP to find and per-
suade colleagues to partake. Due to the novelty of ASP,
some experts declined participation as they claimed they
were not sufficiently progressed with ASP initiatives yet.
As a result, this study assessed only nineteen stake-
holders from nine hospitals in the Dutch border region.
Conclusions of this study do not reflect the entirety of
Dutch hospitals. However, this was not the primary goal
of the study, as we wanted to assess the implementation
process of early ASP initiatives, for which the sample
size sufficed. Another limitation was that by reducing
the number of questions, not every intervention was
assessed in high detail. We also omitted questions re-
garding microbiological diagnostics, infrastructure or
tests and policy forming to keep the questionnaire at
an acceptable length.
To keep the momentum going of ASP implementa-
tions and to improve the chances of success of these
implementations, future research is necessary to obtain
further insights into the rationale and issues that local
experts consider during local implementations. What
considerations did they have and why? At academic hos-
pitals it would be interesting to assess what was learned
with experimentation in pilot implementations. How did
they arrive at the interventions as used in pilots and
how will these pilots be scaled up? Case studies of these
pilots can lead to concrete examples of potential and
different implementations that can be used for advising
other hospitals various configuration possibilities of ASPs.
At non-academic hospitals, future research will be more
focussed on practical issues in implementing ASP. What
do local experts in non-academic hospitals consider in
practice when implementing ASP? What are easily obtain-
able gains? What are barriers?
These different case studies, potential issues and ra-
tionale behind characteristics between interventions can
be used as parameters that influence the configuration
of to-be implemented ASPs. By inventorying all these
parameters, local experts can be supported in customis-
ing and implementing an ASP that fits their hospital.
Eventually, these parameters could be used to synthesise
an implementation maturity toolkit. We plan to design adecision aid for experts in academic and non-academic
hospitals that will generate a customised implementation
advice for ASP fit for their local conditions.
Conclusion
Advising an ASP implementation is not straightforward.
Experts who are tasked to introduce ASPs in their hospi-
tals use expert-driven guidelines but need to transpose
these guidelines to locally implemented interventions.
This transposition leaves leeway for experimentation and
considerations and leads to local differences in imple-
mented intervention and ASPs. Progress can be made by
assisting local experts with implementing ASPs in their
hospitals. This assistance, however, needs to take into
account that local conditions need to be translated into
practical implementation advice and that a ‘one-ASP-
for-all’ advice does not meet the needs of local experts.
A bottom-up assessment with local experts can find pa-
rameters that influence local implementations of ASPs.
These parameters can be used as input for a decision aid
that generates a customised advice for a local implemen-
tation of an ASP.
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